Teva Pharmaceutical Industries Ltd. ADR

Teva Pharmaceutical Industries Ltd. ADR represents the American Depository Receipts of Teva, a prominent global pharmaceutical company headquartered in Israel. The primary function of this ADR is to provide investors in the United States with a convenient means to invest in Teva's equity without directly accessing foreign stock exchanges. Teva is renowned for being one of the largest producers of generic drugs worldwide, focusing on developing therapies to improve the lives of patients across a range of medical conditions. This includes treatments in areas such as central nervous system disorders, oncology, and respiratory issues. In addition to generic medicines, Teva is advancing in specialized medicine, working to bring innovative pharmaceuticals and biosimilars to the market. The ADRs trade on the New York Stock Exchange, offering liquidity and accessibility to U.S. investors while bridging accessibility to Teva’s pharmaceutical innovations. This allows Teva to maintain a significant presence in pharmaceutical markets globally, supporting healthcare systems with a broad portfolio of affordable and effective treatment options.